AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Other drugs, such as pramlintide, can stop glucose levels from rising too far. • Metformin can reduce the amount of sugar the liver produces. • SGLT2 inhibitors, DPP-4 inhibitors, or alpha ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed ...

In January and February, the FDA approved the NovoLog biosimilar MeriLog and issued an alert for diabetes-related smartphone device alerts. In January and February, the Food and Drug Administration ...